Business · 19/12/2017Updated: 10/17/2026 · 1 min read
FDA Announces Public Workshop on Generic Orally Inhaled and Nasal Drug Products
Summary
The FDA is hosting a public workshop to discuss new insights on product development and bioequivalence assessments for generic OINDPs, seeking input on analytical methods and procedures for ANDA submissions.